Drug Shortage Report for LUVOX

Last updated on 2025-01-28 History
Report ID 245725
Drug Identification Number 01919342
Brand name LUVOX
Common or Proper name FLUVOXAMINE MALEATE
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) FLUVOXAMINE MALEATE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 2x15BL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-01-09
Actual start date 2025-01-15
Estimated end date Unknown
Actual end date 2025-01-21
Shortage status Resolved
Updated date 2025-01-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-01-28 French Compare
v10 2025-01-28 English Compare
v9 2025-01-21 French Compare
v8 2025-01-21 English Compare
v7 2025-01-15 French Compare
v6 2025-01-15 English Compare
v5 2025-01-10 English Compare
v4 2025-01-07 French Compare
v3 2025-01-07 English Compare
v2 2024-12-16 French Compare
v1 2024-12-16 English Compare

Showing 1 to 11 of 11